Interleukin-28 and 29 (IL-28 and IL-29): New Cytokines with Anti-Viral Activities

Oppenheim J.J. , and Ruscetti F.W. . 1997. Cytokines. In Medical Immunology, 9th ed. Stites D.P. , Terr A.I. , and Parslow T.G. . Appleton and Lange Stamford Connecticut, p. 146.

Kempuraj D. , Frydas S. , Kandere K. , Madhappan B. , Letourneau R. , Christodoulou S. , Boucher W. , Riccioni G. , Conti P. , and Theoharides T. C. . 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16: 95.

Garbuglia A.R. , Iezzi T. , Capobianchi M.R. , Pignoloni P. , Pulsoni A. , Sourdis J. , Pescarmona E. , Vitolo D. , and Mandelli F. . 2003. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int. J. Immunopathol. Pharmacol. 16: 109.

Mazzoccoli G. , Grilli M. , Carughi S. , Puzzolante F. , De Cata A. , La Viola M. , Giuliani A. , Urbano N. , Tarquini R. , and Perfetto F. . 2003. Immune system alterations in lung cancer patients. Int. J. Immunopathol. Pharmacol. 16: 167.

Roux M.E. , Marquez M.G. , Olmos S. , Frecha C.A. , and Florin–Christensen A. . 2003. Compartmentalisation between Gut and Lung mucosae in a model of secondary immunodeficiency. Effect of thymomodulin. Int. J. Immunopathol. Pharmacol. 16: 151.

He S.C. , Qiao N. , and Sheng W. . 2003. Neurobehavioral, autonomic nervous function and lymphocyte subsets among aluminum electrolytic workers. Int. J. Immunopathol. Pharmacol. 16: 139.

Di Gioacchino M. , Verna N. , Cavalluci E. , Paolini F. , Caruso R. , Grana M. , Schiavone C. , Di Iorio A. , Ramando S. , Reale M. , Paganelli R. , and Theoharides T. C. . 2002. Steroid and antihistamines modulate RANTES release in cultures peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol. 15: 27.

Conti P. , Reale M. , Barbacane R.C. , Castellani M.L. , and Orso C. . 2002. Differential production of RANTES and MCP-I in synovial fluid from the inflamed human knee. Immunol. Lett. 80: 105.

Arena A. , Enzo B. , Enrico G. , Marco B. , and Graziella R. . 2003. Specific immunotheraphy of allergic diseases: a three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16: 277.

Biswas S.K. , and Sodhi A. . 2002. Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: proliferation, colony forming ability signal transduction pathway involved. Int. J. Immunopathol. Pharmacol. 15: 183.

Parrella O. , Parrella M. , Cusumano V. , Ibello U. , Sbreglia C. , De Sena R. , and Perrella A. . 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol. 15: 243.

Huang M. , Berry J. , Kandere K. , Lytinas M. , Karalis K. , and Theoharides T.C. . 2002. Mast cell deficient w/w^v mice lack stress-induced increse in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 15: 249.

Bruno G. , Andreozzi P. , Graf U. , Santangelo G. , Barucco M. , Bruno A. , and Bracchitta S. . 2002. Cetirizinc, a second-generation H1 antagonist, modulates RANTES and MCP-1 levels in allergic rhinitis. Int. J. Immunopathol. Pharmacol. 15: 113.

Riccioni G. , Della Vecchia R. , Castronuovo M. , Di Pietro V. , Spoltore R. , De Benedictis M. , Di Iorio A. , Di Gioacchino M. , and Guagnano M.T. . 2002. Bronchial hyperresponsiveness in adults with seasonal and perennial rhinitis: a link for asthma and rhinitis? Int. J. Immunopathol. Pharmacol. 15: 69

Frydas S. , Madhappan B. , and Kempuraj D. . 2002. Some aspects of parasitology and immunology in general medicine. Int. J. Immunopathol. Pharmacol. 15: 165.

Chiappini E. , Peruzzi M. , Galli L. , Calabri G. , and de Martino M. . 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol. 15: 239.

Macrì M.A. , Di Luzio Sr. , and Di Luzio S. . 2002. Biological effects of electromagnetic fields. Int. J. Immunopathol. Pharmacol. 15: 95.

Rallis T.S. , Frydas S. , Soubasis N. , Adamama-Moraitou K.K. , and Tontis D. . 2002. Monocyte chemotactic protein – 1 in a randomized placebo-controlled study of canine plasmacytic-lymphocytic colitis. Int. J. Immunopathol. Pharmacol. 15: 107.

Yoshino S. , Hayashi H. , Taneda S. , Takano H. , Sagai M. , and Mori Y. . 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15: 13.

Gioia C. , Agrati C. , Goletti D. , Vincenti D. , Carrara S. , Amicosante M. , Casarini M. , Giosue S. , Puglisi G. , Rossi A. , Colizzi V. , Pucillo L.P. , and Poccia F. . 2003. Different cytokine production and effector/memory dynamics of ab⁺ or gd⁺ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16: 247.

Camera E. , Lisby S. , Dell'Anna M.L. , Santucci B. , Paganelli R. , Baadsgaard O. , and Picardo M. . 2003. Mononuclear cell antioxidant pattern and skin reactivity to irritants. Int. J. Immunopathol. Pharmacol. 16: 49.

Longhi C. , Penta M. , Conte M.P. , Girmeniaand C. , Seganti L. . 2003. Heterogeneity of virulence-related properties in listeria monocytogenes strains isolated from patients with haematological malignancies. Int. J. Immunopathol. Pharmacol. 16: 119

Mastrangelo G. , Veller Fornasa C. , Pavanello S. , Marcer G. , Lazzaro M. , Milan G. , Fadda E. , Fedeli U. , and Clonfero E. . 2003. Polyaromatic hydrocarbons administered in humans by dermal route increase total IgE. Int. J. Immunopathol. Pharmacol. 16: 145

Vojdani A. , Pangborn J.B. , Vojdani E. , and Cooper E.L. . 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16: 189

Vecchiet J. , Dalessandro M. , Travasi F. , Falasca K. , Di Iorio A. , Schiavone C. , Zingariello P. , Di Ilio E. , Pizzigallo E. , and Paganelli R. . 2003. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16: 157

Moseley T.A. , Haudenschild D.R. , Rose L. , and Reddi AH. . 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155.

Hurst S.D. , Muchamuel T. , Gorman D.M. , Gilbert J.M. , Clifford T. , Kwan S. , Menon S. , Seymour B. , Jackson C. , Kung T.T. , Brieland J.K. , Zurawski S.M. , Chapman R.W. , Zurawski G. , and Coffman R.L. . 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169: 443

Aarvak T. , Chabaud M. , Miossec P. , and Natvig J.B. . 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162: 1246.

Albanesi C. , Scarponi C. , Cavani A. , Federici M. , Nasorri F. , and Girolomoni G. . 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115: 81

Moore E.E. , Presnell S. , Garrigues U. , Guilbot A. , LeGuern E. , Smith D. , Yao L. , Whitmore T.E. , Gilbert T. , Palmer T.D. , Horner P.J. , and Kuestner R.E. . 2002. Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease. Neuromuscul. Disord. 12: 41.

Shi Y. , Ullrich S.J. , Zhang J. , Connolly K. , Grzegorzewski K.J. , Barber M.C. , Wang W. , Wathen K. , Hodge V. , Fisher C.L. , Olsen H. , Ruben S.M. , Knyazev I. , Cho Y.H. , Kao V. , Wilkinson K.A. , Carrell J.A. , and Ebner R. . 2000. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275: 19167.

Li H. , Chen J. , Huang A. , Stinson J. , Heldens S. , Foster J. , Dowd P. , Gurney A.L. , and Wood W.I. . 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97: 773.

Starnes T. , Broxmeyer H.E. , Robertson M.J. , and Hromas R. . 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169: 642.

Lee J. , Ho W.H. , Maruoka M. , Corpuz R.T. , Baldwin D.T. , Foster J.S. , Goddard A.D. , Yansura D.G. , Vandlen R.L. , Wood W.I. , and Gurney A.L. . 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660.

Pan G. , French D. , Mao W. , Maruoka M. , Risser P. , Lee J. , Foster J. , Aggarwal S. , Nicholes K. , Guillet S. , Schow P. , and Gurney A.L. . 2001. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J. Immunol. 167: 6559.

Starnes T. , Robertson M.J. , Sledge G. , Kelich S. , Nakshatri H. , Broxmeyer H.E. , and Hromas R. . 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167: 4137.

Faour W.H. , Mancini A. , He Q.W. , and Di Battista J.A. . 2003. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J. Biol. Chem. 278: 26897.

Kerins C.A. , Spears R. , Bellinger L.L. , and Hutchins B. . 2003. The prospective use of COX-2 Inhibitors for the treatment of temporomandibular joint inflammatory disorders. Int. J. Immunopathol. Pharmacol. 16(S):1.

Picado C. . 2003. COX-2 specific inhibitors in NSAID-intolerant patients. Int. J. Immunopathol. Pharmacol. 16(S):11.

Van der Bijl P. , and Van der Bijl P. Jr . 2003. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):17.

Pronai L. , Hritz I. , Molnar B. , Herszenyi L. , and Tulassay Z. . 2003. COX-2 selective inhibitors (COXIBS)–gastrointestinal safety. Int. J. Immunopathol. Pharmacol. 16(S):23.

Giovannini M.G. , Scali C. , Prosperi C. , Bellucci A. , Pepeu G. , and Casamenti F. . 2003. Experimental brain inflammation and neurodegeneration as model of Alzheimer's Disease: Protective effects of selective COX-2 inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):31.

Lang S. , and Zeidler R. . 2003. Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: an update. Int. J. Immunopathol. Pharmacol. 16(S):41.

Capone M.L. , Tacconelli S. , Sciulli M.G. , and Patrignani P. . 2003. Clinical pharmacology of selective COX-2 inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):49.

Ramsay R.G. , Ciznadija D. , Vanevski M. , and Mantamadiotis T. . 2003. Transcriptional regulation of cyclooxygenase expression: three pillars of control. Int. J. Immunopathol. Pharmacol. 16(S):59.

Goodman S. B. , Ma T. , Genovese M. , and Lane Smith R. . 2003. COX-2 selective inhibitors and bone. Int. J. Immunopathol. Pharmacol. 16: 201.

Sheppard P. , Kindsvogel W. , Xu W. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nature Immunol. 4: 63.

Pietropaolo V. , Fioriti D. , Simeone P. , Videtta M. , Di Taranto C. , Arancio A. , Orsi N. , and Degener A.M. . 2003. Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects. Int. J. Immunopathol. Pharmacol. 16: 269.

Fioriti D. , Pietropaolo V. , Dal Forno S. , Laurenti C. , Chiarini F. , and Degener A.M. . 2003. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int. J. Immunopathol. Pharmacol. 16: 283.

Trubiani O. , Salvolini E. , Staffolani R. , Di Primio R. , and Mazzanti L. . 2003. DMSO modifies structural and functional properties of RPM1-8402 cells by promoting programmed cell death. Int. J. Immunopathol. Pharmacol. 16: 253.

Ramakrishnan R. , Nazer M.Y. , Suthanthirarajan N. , and Namasivayam A. . 2003. An experimental analysis of the catecholamines in hyperglycemia and acidosis induced rat brain. Int. J. Immunopathol. Pharmacol. 16: 233.

Frydas S. , Hatzistilianou M. , Karagouni E. , Madhappan B. , D'Orazio N. , Riccioni G. , Conti F. , Carratelli G. , and Kempuraj D. . 2003. Chemokines and parasites. Int. J. Immunopathol. Pharmacol. 16: 221.

Addolorato G. , Ancona C. , Capristo E. , and Gasbarrini G. . 2003. Metadoxine in the treatment of acute and chronic alcoholism: a review. Int. J. Immunopathol. Pharmacol. 16: 207.

Kaneider N.C. , Kaser A. , Tilg H. , Ricevuti G. , and Wiedermann C.J. . 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16: 225.